KM	Haemophilus influenzae	0.0079	UDP-2,3-diacylglucosamine	*pH 8.0, 30&Acirc;&deg;C
KM	Caulobacter vibrioides	0.105	UDP-2,3-diacylglucosamine	*in 100 mM sodium acetate, 50 mM bis(2-hydroxyethyl)imino-tris(hydroxymethyl)hexane, and 50 mM Tris, 2 mM MgCl2, at 30&Acirc;&deg;C, pH not specified in the publication
KM	Escherichia coli	0.0617	UDP-N2,O3-bis((3R)-3-hydroxymyristoyl)-alpha-D-glucosamine	*pH 8.0, 30&Acirc;&deg;C
MW	Escherichia coli	26893	*	*x * 26893, calculated from sequence
PATH	*	lipid A biosynthesis	*	*
PATH	*	lipid IVA biosynthesis (E. coli)	*	*
PATH	*	lipid IVA biosynthesis (P. putida)	*	*
PATH	*	Lipopolysaccharide biosynthesis	*	*
PATH	*	Metabolic pathways	*	*
SA	Haemophilus influenzae	7.8	*	*pH 8.0, 30&deg;C
SA	Caulobacter vibrioides	25	*	*membane-free lysate, in 100 mM sodium acetate, 50 mM bis(2-hydroxyethyl)imino-tris(hydroxymethyl)hexane, and 50 mM Tris, 2 mM MgCl2, at 30&deg;C, pH not specified in the publication
SA	Caulobacter vibrioides	30	*	*after 1.2fold purification, in 100 mM sodium acetate, 50 mM bis(2-hydroxyethyl)imino-tris(hydroxymethyl)hexane, and 50 mM Tris, 2 mM MgCl2, at 30&deg;C, pH not specified in the publication
SA	Escherichia coli	63.2	*	*
